Article

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escape

2021-04-08

Abstract excerpt

An ideal anti-SARS-CoV-2 antibody would resist viral escape 1–3 , have activity against diverse SARS-related coronaviruses 4–7 , and be highly protective through viral neutralization 8–11 and effector functions 12,13 . Understanding how these properties relate to each other and vary across epitopes would aid development of antibody therapeutics and guide vaccine design. Here, we comprehensively characterize es...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: ac79fc54-1030-5972-b21d-bd744bb0d174
DOI: 10.1101/2021.04.06.438709

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

Antibodies to the SARS-CoV-2 receptor-binding domain that maximize breadth and resistance to viral escapeDOI 10.1101/2021.04.06.438709Read

Comprehensive Mapping of Binding Hot Spots of SARS-CoV-2 RBD-specific Neutralizing Antibodies for Tracking Immune Escape VariantsSemantic proximity Read

Structural and mutational analyses define distinct molecular routes to broad SARS-CoV-2 receptor-binding domain recognitionSemantic proximity Read

A broad and potent neutralization epitope in SARS-related coronavirusesSemantic proximity Read

Evaluating SARS-CoV-2 Antibody Resilience via Prediction and Design of Escape Viral VariantsSemantic proximity Read

Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicrySemantic proximity Read

Mutational analysis of SARS-CoV-2 variants of concern reveals key tradeoffs between receptor affinity and antibody escape.Semantic proximity Read

Massively Multiplexed Affinity Characterization of Therapeutic Antibodies Against SARS-CoV-2 VariantsSemantic proximity Read

Structural basis for continued antibody evasion by the SARS-CoV-2 receptor binding domain.Semantic proximity Read

Prospective mapping of viral mutations that escape antibodies used to treat COVID-19Semantic proximity Read

Antibody drugs targeting SARS-CoV-2: Time for a rethink?Semantic proximity Read

Broad Neutralization Activity of SARS-CoV-2 Antibody is Achieved by Coordinated Recognition of Virus Vulnerable SiteSemantic proximity Read

A potent pan-sarbecovirus neutralizing antibody resilient to epitope diversificationSemantic proximity Read